Burcon NutraScience (NASDAQ:BRCN) reported quarterly losses of $(0.04) per share. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.
Nutriband Signs Commercial Development And Clinical Supply Agreement With Kindeva Drug Delivery For Aversa Fentanyl, An Abuse Deterrent Fentanyl Patch
Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has signed a commercial development and clinical supply agreement for their lead